Profound Medical Corp. (TSX:PRN)

Profound Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	38.27	59.72	54.91	26.21	46.52	67.15
Cash & Short-Term Investments	38.27	59.72	54.91	26.21	46.52	67.15
Cash Growth	8.74%	8.76%	109.48%	-43.65%	-30.73%	-19.97%
Accounts Receivable	9.01	7.2	6.43	6.75	5.84	1.41
Other Receivables	0.61	-	0.62	0.53	0.51	-
Receivables	9.61	7.2	7.05	7.29	6.34	1.41
Inventory	10.46	8.24	5.8	6.99	7.94	7.41
Prepaid Expenses	0.52	0.93	1.31	1.41	1.22	1.15
Total Current Assets	58.86	76.09	69.07	41.9	62.02	77.13
Property, Plant & Equipment	3.32	0.88	0.82	1.57	1.72	1.9
Goodwill	-	-	-	-	-	2.69
Other Intangible Assets	0.12	0.14	0.26	0.49	0.68	1.44
Long-Term Accounts Receivable	-	0.3	-	-	-	3.62
Long-Term Deferred Tax Assets	0.08	0.07	0.09	-	-	-
Total Assets	62.39	77.48	70.23	43.96	64.42	86.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.96	1.56	1.32	0.87	2.03	3.18
Accrued Expenses	3.13	3.82	2.84	2.42	-	-
Current Portion of Long-Term Debt	4.51	-	1.74	2.1	0.52	-
Current Portion of Leases	0.12	0.21	0.26	0.26	0.24	0.25
Current Income Taxes Payable	0.06	0.04	-	-	0.3	-
Current Unearned Revenue	0.34	0.45	0.42	0.72	0.47	0.48
Other Current Liabilities	-	-	-	-	0.62	0.25
Total Current Liabilities	9.11	6.08	6.57	6.37	4.18	4.16
Long-Term Debt	-	4.5	2.92	5	6.65	-
Long-Term Leases	2.75	-	0.2	0.5	0.82	1.13
Long-Term Unearned Revenue	0.62	0.39	0.05	0.73	0.76	0.88
Long-Term Deferred Tax Liabilities	-	-	-	0.06	-	-
Other Long-Term Liabilities	0.09	0.08	0.07	0.07	-	-
Total Liabilities	12.58	11.04	9.81	12.73	12.42	6.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	325.38	323.84	281.55	222.21	205.83	219.58
Additional Paid-In Capital	25.69	25.31	21.3	20.81	18.7	16.99
Retained Earnings	-304.33	-287.74	-245.17	-217.35	-189.36	-160.69
Comprehensive Income & Other	3.07	5.03	2.74	5.57	16.84	4.75
Shareholders' Equity	49.81	66.43	60.42	31.22	52	80.62
Total Liabilities & Equity	62.39	77.48	70.23	43.96	64.42	86.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	7.38	4.71	5.12	7.87	8.23	1.38
Net Cash (Debt)	30.89	55.01	49.79	18.35	38.29	65.78
Net Cash Growth	1.68%	10.48%	171.40%	-52.08%	-41.79%	-20.02%
Net Cash Per Share	0.93	1.82	2.01	0.87	1.84	3.21
Filing Date Shares Outstanding	36.53	36.29	30.04	24.43	20.91	20.78
Total Common Shares Outstanding	36.53	36.29	30.04	21.37	20.88	20.78
Working Capital	49.75	70.01	62.5	35.53	57.84	72.97
Book Value Per Share	1.36	1.83	2.01	1.46	2.49	3.88
Tangible Book Value	49.69	66.3	60.16	30.73	51.32	76.49
Tangible Book Value Per Share	1.36	1.83	2.00	1.44	2.46	3.68
Machinery	0.18	0.18	-	-	0.54	1.2
Leasehold Improvements	0.54	0.54	0.54	0.54	1.84	0.58

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error